Jeffrey Dierks, Chief Commercial Officer at Harmony Biosciences Holdings, Inc. (HRMY), sold 17,036 shares at $40.02 ($682K) on 2022-02-17, disclosed to the SEC on 2022-02-18.
Open-market sale of $682k HRMY by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.05 | 4,259 | $171K | 25.0% |
| 2 | $40.05 | 4,259 | $171K | 25.0% |
| 3 | $40.02 | 4,259 | $170K | 25.0% |
| 4 | $40.02 | 4,259 | $170K | 25.0% |
| Total | $40.03 avg | 17,036 | $682K | 100% |
| Filing → |
| HRMY | SELL | 2025-01-21 | $2.3M | — | Filing → |
| HRMY | SELL | 2025-01-16 | $778K | — | Filing → |
| HRMY | SELL | 2025-01-15 | $532K | — | Filing → |